Anxiety Disorders Completed Phase 2 Trials for Escitalopram (DB01175)

Also known as: Anxiety Disorder / Anxiety NOS

IndicationStatusPhase
DBCOND0027904 (Anxiety Disorders)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02469545Effect of Lactobacillus Plantarum 299v Supplementation on Major Depression TreatmentTreatment